This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated HIRA Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-HIRA WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~111.8 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Ubl conjugation | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The M03101 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HeLa cell lysate (catalog M03101) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M03101; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
HIRA is predicted at 111.8 kDa; Long and Short isoforms could affect band patterns, but distinct migration has not been demonstrated.
| Band near 111.8 kDa | Consistent with the UniProt predicted mass; identity requires controls |
| Single band without a doublet | Long and Short isoforms may not resolve into separate bands |
| Two bands at different positions | Long and Short isoforms are possible contributors; confirm their identities |
| Upper band of a pair | Could represent the Long isoform if the isoforms resolve |
| Lower band of a pair | Could represent the Short isoform if the isoforms resolve |
| UniProt predicted mass | Sets a 111.8 kDa reference for the supplied sequence |
| Alternative splicing | May change apparent size; distinct bands are not established |
| Long isoform | Could migrate above Short if their sizes differ enough to resolve |
| Short isoform | Could migrate below Long if their sizes differ enough to resolve |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | HIRA is primarily nuclear and may be poorly represented in the sampled fraction | Check a nuclear fraction and a positive control |
| Band higher than expected | An isoform or an unrelated band could account for the position; no shifted mass is established | Confirm identity with HIRA knockdown and a second antibody |
| Band lower than expected | The Short isoform is possible, but its mass is not supplied | Confirm identity with isoform-specific evidence or HIRA knockdown |
| Multiple bands | Long and Short isoforms are annotated, though distinct migration is unproven | Compare bands after HIRA knockdown or with a second antibody |
| Weak or no signal | Nuclear HIRA may be underrepresented in the preparation | Enrich the nuclear fraction and verify sample loading |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | High | Protein (IHC) | HPA → |
| Caudate | neuronal cells | High | Protein (IHC) | HPA → |
| Cervix | glandular cells | High | Protein (IHC) | HPA → |
| Colon | endothelial cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Medium | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Medium | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Cerebellum | cells in granular layer | Medium | Protein (IHC) | HPA → |
| Cerebral cortex | endothelial cells | Medium | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for HIRA, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
M03101 is a rabbit monoclonal anti-HIRA antibody listed for human reactivity. Its Western blot image shows HIRA expression in HeLa cell lysate; the supplied evidence does not establish performance across other samples or species.
Which to pick: Only M03101 is listed. Choose it for a human HIRA Western blot when the HeLa cell lysate example is relevant to your experiment; check suitability separately for other sample types.